Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 2 Lymphoma, Non-Hodgkin 2 Leukemia 2 Hematologic Neoplasms 2 Plasmacytoma 1 Neoplasms 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Carcinoma, Hepatocellular 1 Advanced Gastric Cancer 1

Interventions

Paclitaxel 6 apatinib 4 camrelizumab 3 S 1 (combination) 2 Capecitabine 2 130-nm albumin-bound paclitaxel 2 vorolanib 1 titanium silicide 1 spartalizumab 1 raltitrexed 1 olaparib 1 lobaplatin 1 durvalumab 1 Ramucirumab 1 Oxaliplatin 1 Gastrectomy 1 Docetaxel 1 Control Groups 1 Cisplatin 1 CF regimen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Advanced Gastric Cancer × CF regimen × Clear all

NCT00992199 2010-09-08

IPchemo-AGC

Fudan University

Phase 2 Unknown

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡